U.S. Markets closed

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3825+0.0065 (+1.73%)
At close: 03:33PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3760
Bid0.3601 x 1000
Ask0.3850 x 900
Day's Range0.3735 - 0.3850
52 Week Range0.2300 - 2.4600
Avg. Volume1,008,635
Market Cap8.777M
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks Small Cap Research

    AEMD: New CRO to Help Advance Studies; Expanded Team to Facilitate Efforts

    By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT New CRO to facilitate study of the Hemopurifier® in a range of cancers To advance its medical device, the HemoPurifier®, through clinical studies towards potential regulatory approval and commercialization, Aethlon Medical’s (NASDAQ:AEMD) has launched several recent initiatives. Among other steps, the company has: ▪ Embarked on launching

  • PR Newswire

    Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

    Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its third quarter ended December 31, 2022 and provided an update on recent developments.

  • PR Newswire

    Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

    Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, announced today that it will be presenting virtually at the upcoming Sequire Biotechnology Conference on Thursday, February 2nd, at 10:00 AM ET. Steven LaRosa, M.D., Chief Medical Officer and Chief Scientific Officer of Aethlon Medical, will be giving the presentation.